Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:SNOW
NYSE:SNOWIT

A Look At Snowflake (SNOW) Valuation As AI Growth And New Marketplace Apps Draw Market Attention

Snowflake (SNOW) is back in focus after Penguin Ai launched healthcare focused prior authorization and medical coding Snowflake Native Apps on Snowflake Marketplace, spotlighting how third party AI workloads are increasingly built directly on its data platform. See our latest analysis for Snowflake. Snowflake’s recent client wins and AI focused launches sit against a mixed share price backdrop, with a 7 day share price return of 18.88%, a 30 day share price return decline of 16.89%, and a...
NasdaqGS:GSAT
NasdaqGS:GSATTelecom

Amazon’s Globalstar Deal Reframes Direct To Device Opportunity For Investors

Amazon has entered a definitive agreement to acquire Globalstar, giving it direct access to Globalstar's satellite assets and spectrum for direct to device services. The deal positions Amazon to offer satellite based connectivity beyond traditional terrestrial networks. The agreement marks a material shift for Globalstar and the wider satellite communications industry. For investors watching NasdaqGS:GSAT, this agreement comes after a period of very strong share price performance...
NasdaqCM:VKTX
NasdaqCM:VKTXBiotechs

Assessing Viking Therapeutics (VKTX) Valuation After Strong Multi‑Year Share Price Gains

If you are wondering whether Viking Therapeutics is still reasonably priced after its recent run, this breakdown will help you frame what the current share price might be implying. The stock closed at US$35.20, with returns of 2.7% over 7 days, 4.9% over 30 days, a small year to date decline of 0.6%, and gains of 47.0% over 1 year and 66.0% over 3 years. These moves sit against a backdrop of ongoing interest in the company as a clinical stage biotech name, with investors reacting to trial...
NYSE:DE
NYSE:DEMachinery

Deere’s Right-to-Repair Settlement Might Change The Case For Investing In Deere (DE)

In early April 2026, Deere & Company reached a settlement to resolve multidistrict “right to repair” litigation in US federal court, agreeing to fund a class settlement pool and maintain access to tools, manuals, and diagnostic software for equipment repairs, pending court approval. This outcome not only closes a high-profile legal chapter without a finding of wrongdoing, but also reinforces Deere’s commitment to broader repair access and ongoing investment in customer uptime solutions and...
NasdaqGS:RIVN
NasdaqGS:RIVNAuto

How Does Rivian’s (RIVN) Second-Life Battery Project Reframe Its Technology Integration Narrative?

On 14 April 2026, Rivian and Redwood Materials announced they had deployed a 10 megawatt-hour second-life battery energy storage system at Rivian’s Normal, Illinois plant using more than 100 repurposed Rivian EV battery packs to help cut energy costs and ease pressure on the grid during peak demand. This partnership introduces the first repurposed EV battery energy storage system at a U.S. automaker’s manufacturing facility, highlighting how Rivian can extend battery life, support grid...
ENXTBR:AGS
ENXTBR:AGSInsurance

Is It Time To Reassess ageas (ENXTBR:AGS) After Strong Multi‑Year Share Price Gains

Wondering if ageas shares are offering fair value at around €68.20, or if the current price is out of line with fundamentals? This article breaks down what the numbers say. With returns of 1.8% over the past week, 11.3% over the last month, 12.1% year to date and 34.8% over the past year, plus 96.2% over three years and 74.7% over five years, ageas has given investors plenty to think about when weighing up value versus price. Recent coverage around ageas has focused on its position within...
TSX:USA
TSX:USAMetals and Mining

A Look At Americas Gold And Silver (TSX:USA) Valuation After Record Silver Output And Operational Upgrades

Americas Gold and Silver (TSX:USA) drew fresh attention after reporting record first quarter silver production of 787,000 ounces, record sales of 830,000 ounces, and progress on key upgrades at its Galena Complex. See our latest analysis for Americas Gold and Silver. The latest production milestones sit alongside a CA$8.96 share price, with strong recent momentum shown by a 15.17% 7 day share price return and 28.00% year to date share price return. Over a longer horizon, a very large 1 year...
NasdaqGM:MRLN
NasdaqGM:MRLNAerospace & Defense

Assessing Merlin (MRLN) Valuation After New Chief Revenue Officer Appointment

Why Merlin’s CRO Appointment Matters for Shareholders Merlin (MRLN) is in focus after appointing Mark Brunner as Chief Revenue Officer. This move is tied to scaling its Merlin Pilot across defense and civil aviation customers as the company advances as a public issuer. See our latest analysis for Merlin. The appointment of a revenue focused leader like Brunner comes as Merlin’s share price sits at US$13.58, with a 1 day share price return of a 15.6% decline, alongside strong recent momentum...
NYSE:FHN
NYSE:FHNBanks

First Horizon Expands Gulf South Leadership To Support Earnings Mix Shift

First Horizon (NYSE:FHN) has announced a series of leadership hires and internal promotions. The moves focus on strengthening commercial and private client banking teams in the Acadiana and New Orleans markets. These changes are aimed at deepening client relationships and expanding regional banking capabilities. For a regional bank like First Horizon, commercial and private client banking sit at the core of how it serves businesses and high net worth clients. Recent trends in U.S. banking...
NasdaqGS:MKSI
NasdaqGS:MKSISemiconductor

MKS Leadership Shift Burke Retirement And Valuation Questions For Investors

MKS (NasdaqGS:MKSI) announced the retirement of Kathleen F. Burke as Executive Vice President, General Counsel and Secretary. Her retirement affects the senior leadership team that oversees legal, compliance and corporate governance. For investors tracking MKS at a share price of $278.59, this leadership change follows a period of stock performance in which the company was up 3.7% over the past week and 19.4% over the past month. Returns of 65.5% year to date and 340.4% over the past year...
NYSE:OWL
NYSE:OWLCapital Markets

A Look At Blue Owl Capital (OWL) Valuation As Dividend Yield Tops 11% In Volatile Private Credit Conditions

Dividend yield jumps as investors weigh private credit risks Investor focus on Blue Owl Capital (OWL) has intensified after its dividend yield moved above 11%, at the same time the private credit market remains volatile and direct lending products face ongoing pressure. The company is paying out more in dividends than it currently earns, resulting in payout ratios above 100%. Management has signaled an intention to bring those ratios down over the coming years without changing the fixed 2026...
NYSE:BWXT
NYSE:BWXTAerospace & Defense

What BWX Technologies (BWXT)'s Planned Erwin Enrichment Facility Means For Shareholders

In early April 2026, BWX Technologies notified the U.S. Nuclear Regulatory Commission that it plans to seek a uranium enrichment license for a new facility beside its Nuclear Fuel Services site in Erwin, Tennessee, to support a US$1.50 billion NNSA contract and future naval reactor fuel needs. The project, which will use Oak Ridge National Laboratory centrifuge technology and is expected to create around 100 high-skill jobs once operating near 2035, marks a meaningful move to strengthen U.S...
SEHK:9995
SEHK:9995Biotechs

Why RemeGen (SEHK:9995) Is Up 13.1% After First HER2 ADC–Immunotherapy Approval in China

RemeGen announced that China’s NMPA has approved a new indication for its antibody-drug conjugate Disitamab Vedotin, in combination with Toripalimab, to treat HER2-expressing locally advanced or metastatic urothelial carcinoma, marking the drug’s fifth approved use in China. This approval is underpinned by a large Phase III trial showing the combo outperformed standard platinum-based chemotherapy across the full spectrum of HER2 expression, reinforcing the clinical relevance of pairing...
NasdaqGS:CMCSA
NasdaqGS:CMCSATelecom

Comcast’s Mario Film Success And What It May Mean For Valuation

Comcast (NasdaqGS:CMCSA) is the distribution partner behind "The Super Mario Galaxy Movie," currently 2026's highest grossing film. The film extends Comcast's entertainment partnership with Nintendo and highlights its role in high profile animated releases. This box office success adds a fresh element to Comcast's broader mix across broadband, streaming, and content. For investors watching NasdaqGS:CMCSA at a share price of $29.63, this news sits alongside mixed longer term share...
NasdaqGS:PI
NasdaqGS:PISemiconductor

A Fresh Look At Impinj (PI) Valuation As Mixed Returns Shape An Undervalued Story

Event driven snapshot on Impinj stock Impinj (PI) is back on investor watchlists after recent trading, with the share price at US$112.28 and short term returns mixed, including a monthly gain alongside a decline over the past 3 months. See our latest analysis for Impinj. The recent 13.83% 1 month share price return and 10.58% 7 day share price return contrast with a 30.66% 3 month share price decline and a 37.54% year to date share price decline. The 1 year total shareholder return of 63.51%...
ENXTAM:PHIA
ENXTAM:PHIAMedical Equipment

Is Philips (ENXTAM:PHIA) Offering Value After Recent Healthcare Technology Scrutiny?

If you are wondering whether Koninklijke Philips is priced fairly today, the key question is whether the current share price reflects what the business might be worth over the long term. The stock last closed at €25.35, with returns of 4.4% over 7 days, 5.2% over 30 days, 9.6% year to date, 26.0% over 1 year, 64.4% over 3 years, and a 40.2% decline over 5 years. Recent headlines around Koninklijke Philips have focused on the company’s position in global healthcare technology and ongoing...